CUX1 and glioma: Similarly, A172 glioma cells also exhibited enhanced migration and invasion capability when treated with the CUX1 overexpression plasmid compared to the empty vector, while attenuated migration was observed following transfection with CUX1 siRNA (p < 0.05, Figures 4A–D).